Biome Lift trial update positive results received
Filed with ASX · · 4 pages · English
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings CallIn the deck
Story so far
Earlier from Biome Australia
- Full year revenue guidance FY23
- Biome secures $1.2 million revolving debt facility
- Biome surpasses $7m sales revenue target
- Correction to Quarterly Activities Report
- Biome delivers record quarterly sales in Q3 FY23
Later from Biome Australia
- Biome Lift Clinical Trial Presentation
- Biome expects first month of positive EBITDA in FY24
- Revenue Update
- Biome signs landmark agreement to develop IP
- Biome to launch cholesterol reducing probiotic
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia